During the past decade, CCOP - Scottsdale Oncology Program conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CCOP - Scottsdale Oncology Program" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 61 trials, followed by "Eastern Cooperative Oncology Group" with 16 trials sponsored, "SWOG Cancer Research Network" with 5 trials sponsored, "National Cancer Institute (NCI)" with 3 trials sponsored and "Celgene" with 3 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CCOP - Scottsdale Oncology Program" #1 collaborator was "National Cancer Institute (NCI)" with 85 trials as a collaborator, "North Central Cancer Treatment Group" with 10 trials as a collaborator, "Eastern Cooperative Oncology Group" with 8 trials as a collaborator, "Cancer and Leukemia Group B" with 4 trials as a collaborator and "NCIC Clinical Trials Group" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "CCOP - Scottsdale Oncology Program" are "Lung Cancer" (17 trials), "Breast Cancer" (15 trials), "Colorectal Cancer" (12 trials), "Lymphoma" (9 trials) and "Leukemia" (6 trials). Many other conditions were trialed in "CCOP - Scottsdale Oncology Program" in a lesser frequency.

Most popular intervention types in "CCOP - Scottsdale Oncology Program" are "Drug" (84 trials), "Radiation" (18 trials), "Biological" (16 trials), "Other" (12 trials) and "Procedure" (7 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (13 trials), "gemcitabine hydrochloride" (12 trials), "placebo" (11 trials), "carboplatin" (9 trials) and "cisplatin" (9 trials). Other intervention names were less common.

The vast majority of trials in "CCOP - Scottsdale Oncology Program" are 86 trials for "All" genders, 9 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "CCOP - Scottsdale Oncology Program". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 97 completed trials in CCOP - Scottsdale Oncology Program, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in CCOP - Scottsdale Oncology Program, 5 "Phase 1" clinical trials were conducted, 64 "Phase 2" clinical trials and 28 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".